Nystatin Oral Suspension
CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.
Yes — there is an active recall. 6 ongoing FDA recalls mention Nystatin (30 total). Check the affected lots below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Nystatin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.
Labeling: label error on declared strength.
Labeling: label error on declared strength.
Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.
Failed Impurites/Degradation Specifications: Test failure of single largest peak at 18 months.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.